ReviewJournal of inflammation research2025
Advances in Necrotizing Fasciitis Animal Models: Current Trends and Future Perspectives.
Review in Journal of inflammation research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Necrotizing fasciitis (NF) is a rapidly progressive soft tissue infection with high morbidity and mortality, yet its pathophysiology remains incompletely understood. Animal models are indispensable for dissecting disease mechanisms and testing therapeutic interventions, yet their translational relevance varies across species and experimental approaches. This review critically evaluates NF models in rodents, zebrafish, rabbits, pigs, and non-human primates, highlighting their relative strengths in replicating immunopathology, systemic dissemination, and biofilm-driven persistence. We examine methodological strategies including bacterial inoculation, trauma-induced infection, immunosuppression-enhanced infection, genetic engineering, and optical imaging, and discuss how these frameworks capture discrete aspects of NF pathogenesis. Emerging technologies, including CRISPR-mediated host factor engineering, multi-omics profiling, intravital and high-resolution imaging, organ-on-chip platforms, and artificial intelligence, are integrated into next-generation models to enhance predictive power, mechanistic insight, and translational fidelity. We also outline innovative therapeutic strategies validated in preclinical models, from precision-targeted monoclonal antibodies and immunotherapies to advanced drug delivery systems and AI-guided predictive modeling. Finally, we discuss practical and ethical considerations for NF modeling, emphasizing reproducibility, standardization, and the 3Rs principle, and propose a forward-looking framework for integrating in vivo, in vitro, and in silico platforms. Collectively, these insights provide a roadmap for refining NF animal models, accelerating mechanistic discovery, and informing clinically relevant interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.